NorthWest Biotherapeutics Inc (NWBO)

[iclight]

Only one GBM patient in the Poly-ICIC arm lived over 4 years. None of the other 4 lived over 29 months.

The longest living GBM patient between the placebo arm and the Poly-ICIC was in the placebo arm. The only one who lived over 5 years.

So this trial shows the following:

Only one of the 15 GBM patients in this trial lived over 5 years. Therefore the 5 year OS expectancy of a GBM patient receiving DCVax is 1/15 = 6%. About what is expected from SOC.

Thanks UCLA for proving your own treatment doesn't work. See what we can conclude from following breadcrumbs?